8 results
8-K
EX-99.1
VRDN
Viridian Therapeutics Inc
8 Jan 24
Viridian Therapeutics to Present Key 2024 Corporate Priorities at J.P. Morgan Healthcare Conference
8:08am
an integral part of the Viridian team throughout his tenure and will continue to lead our clinical development efforts as Chief Medical Officer,” said
8-K
EX-99.1
VRDN
Viridian Therapeutics Inc
30 Oct 23
Entry into a Material Definitive Agreement
8:35am
was able to achieve during his tenure,” said Tomas Kiselak, Chairman of Viridian’s Board of Directors. “The Board believes that the transition to Steve’s
- Prev
- 1
- Next